Laws Requiring the E-Prescribing of Opioids Have Gained Momentum, but Prescriber Adoption is Playing Catch Up

The SUPPORT for Patients and Communities Act, which Congress passed and President Trump signed into law in October, mandates the use of electronic prescribing of controlled substances (EPCS) for all controlled substances under Medicare Part D by January 1, 2021.

EPCS is a critical tool in the nation's response to the epidemic. It eliminates paper prescriptions, which can be stolen, forged or altered, and gives prescribers electronic access to a patient’s prescription history to help identify potential overuse or abuse. In addition, there are other benefits, including enhanced security, privacy and prescribing flexibility, as well as improved workflow efficiency for prescribers and pharmacists alike.

Policymakers clearly see the need to leverage EPCS in the fight against opioid abuse, as the continued acceleration of EPCS legislation at the state level demonstrates. In 2018, eight more states passed mandates--Arizona, California, Iowa, Massachusetts, New Jersey, Oklahoma, Pennsylvania and Tennessee—bringing the total number of states with EPCS mandates to 15. Of that total, the mandates in Arizona, New Jersey and Pennsylvania become effective in 2019—with Arizona’s beginning the very first day of the new year. Michigan and Illinois have now introduced EPCS bills, and industry experts expect nearly twenty more states to pursue similar legislation in 2019.

The full Surescripts article can be found at this link.